Paid Clinical Trials Indianapolis
Discover 885 paid clinical trials in Indianapolis, Indiana. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Endovascular Therapy for Low NIHSS Ischemic Strokes
Sponsor:
Emory University
Location:
Code:
NCT04167527
Conditions
Cerebral Ischemia
Eligibility Criteria
Sex: All
Age: 18+
Healthy Volunteers: Not accepted
Interventions
Immediate mechanical thrombectomy(iMT) using EmboTrap Revascularization Device
Initial medical management (iMM)
Adenovirus-specific Cytotoxic T-lymphocytes for Refractory Adenovirus Infection
Sponsor:
New York Medical College
Location:
Code:
NCT03266627
Conditions
Adenovirus
Primary Immune Deficiency Disorder
Eligibility Criteria
Sex: All
Age: 1 - 70+
Healthy Volunteers: Not accepted
Interventions
cytotoxic t-lymphocytes
Osimertinib With or Without Bevacizumab as Initial Treatment for Patients With EGFR-Mutant Lung Cancer
Sponsor:
National Cancer Institute (NCI)
Location:
Code:
NCT04181060
Conditions
Advanced Lung Non-Squamous Non-Small Cell Carcinoma
Metastatic Lung Non-Squamous Non-Small Cell Carcinoma
Recurrent Lung Non-Squamous Non-Small Cell Carcinoma
Stage IIIB Lung Cancer AJCC v8
Stage IV Lung Cancer AJCC v8
Eligibility Criteria
Sex: All
Age: 18+
Healthy Volunteers: Not accepted
Interventions
Bevacizumab
Biospecimen Collection
Computed Tomography
Echocardiography
Magnetic Resonance Imaging
Real-world Clinical Outcomes of the MITRIS RESILIA Mitral Valve
Sponsor:
Edwards Lifesciences
Location:
Code:
NCT05526560
Conditions
Mitral Stenosis
Mitral Valve Insufficiency
Eligibility Criteria
Sex: All
Age: 18+
Healthy Volunteers: Not accepted
Interventions
MITRIS RESILIA Mitral Valve, Model 11400M
Consolidation of First-Line MRD+ Remission With Cema-cel in Patients With LBCL
Sponsor:
Allogene Therapeutics
Location:
Code:
NCT06500273
Conditions
Large B-cell Lymphoma
Eligibility Criteria
Sex: All
Age: 18+
Healthy Volunteers: Not accepted
Interventions
cemacabtagene ansegedleucel
ALLO-647
Fludarabine
Cyclophosphamide
Foresight CLARITY™ IUO MRD test, powered by PhasED-Seq™
Intravenous Iron in Combination with Standard of Care Immunotherapy in Melanoma
Sponsor:
Indiana University
Location:
Code:
NCT06508827
Conditions
Anemia, Iron Deficiency
Melanoma
Eligibility Criteria
Sex: All
Age: 18+
Healthy Volunteers: Not accepted
Interventions
Iron dextran 1000 mg IV
The Willow LTE Study With M5049 in Participants With SCLE, DLE and/or SLE (WILLOW LTE)
Sponsor:
Merck Healthcare KGaA, Darmstadt, Germany, an affiliate of Merck KGaA, Darmstadt, Germany
Location:
Code:
NCT05540327
Conditions
Systemic Lupus Erythematosus
Eligibility Criteria
Sex: All
Age: 18 - 70+
Healthy Volunteers: Not accepted
Interventions
M5049 low dose
M5049 medium dose
M5049 high dose
Placebo
M5049 very high dose
Interventional Study Exploring the Occurrence of Surgical Site Infections.
Sponsor:
Molnlycke Health Care AB
Location:
Code:
NCT06661473
Conditions
Total Knee Arthroplasty
Total Hip Arthroplasty Revision
Total Knee Arthroplasty Revision
Eligibility Criteria
Sex: All
Age: 18+
Healthy Volunteers: Not accepted
Interventions
Avance Solo Negative Pressure Wound Therapy
A Study of TAK-186 (Also Known as MVC-101) in Adults With Advanced or Metastatic Cancer
Sponsor:
Takeda
Location:
Code:
NCT04844073
Conditions
Squamous Cell Cancer of Head and Neck (SCCHN)
Non-small Cell Lung Cancer (NSCLC)
Colorectal Cancer
Eligibility Criteria
Sex: All
Age: 18+
Healthy Volunteers: Not accepted
Interventions
TAK-186